Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 216 participants.
Also called NCT06945809
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 216 participants
- Sponsor
- Hangzhou Endonom Medtech Co., Ltd.
- Registry
-
NCT06945809
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06945809. Randomized; no masking; primary purpose treatment. Start 2026-07-13 (actual); primary completion 2028-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
- Acronym
- Gallant
- Condition
- Aortic Dissection
- Condition
- Distal Entry Tear
- Intervention (Device)
- WeFlow-EndoPatch Aortic Endovascular Patch System
- Intervention (Other)
- Conventional Treatment group
- Lead sponsor
- Hangzhou Endonom Medtech Co., Ltd.
Record details
- Record id
cardio:ct-nct06945809- Content hash
0a1044c33be4b4e9c13b3f041d656930a6c1aea79ed5a51b2ac6f560d61f4ab1